Abstract:Journal of Medical VirologyVolume 92, Issue 10 p. 1764-1766 LETTER TO THE EDITOR Influenza-like illnesses caused by a cluster of imported Italian COVID-19 Wei Wang, Wei Wang Department of Pathogen Biology & Microbiology, and Department of General Intensive Care Unit of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China Clinical Laboratory of Lishui People's Hospital, Lishui, Zhejiang, ChinaSearch for more papers by this authorDajin Zhou, Dajin Zhou Clinical Laboratory, The Second People's Hospital of Lishui, Lishui, Zhejiang, ChinaSearch for more papers by this authorXu Jia, Xu Jia orcid.org/0000-0002-1612-1136 Noncoding RNA and Drug Discovery Key Laboratory of Sichuan Province, Chengdu Medical College, Chengdu, Sichuan, ChinaSearch for more papers by this authorYoujun Feng, Corresponding Author Youjun Feng [email protected] orcid.org/0000-0001-8083-0175 Department of Pathogen Biology & Microbiology, and Department of General Intensive Care Unit of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China Clinical Laboratory of Lishui People's Hospital, Lishui, Zhejiang, China Noncoding RNA and Drug Discovery Key Laboratory of Sichuan Province, Chengdu Medical College, Chengdu, Sichuan, China College of Animal Sciences, Zhejiang University, Hangzhou, Zhejiang, China Correspondence Youjun Feng, Department of Pathogen Biology & Microbiology, and Department of General Intensive Care Unit of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310058 Zhejiang, China. Email: [email protected]Search for more papers by this author Wei Wang, Wei Wang Department of Pathogen Biology & Microbiology, and Department of General Intensive Care Unit of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China Clinical Laboratory of Lishui People's Hospital, Lishui, Zhejiang, ChinaSearch for more papers by this authorDajin Zhou, Dajin Zhou Clinical Laboratory, The Second People's Hospital of Lishui, Lishui, Zhejiang, ChinaSearch for more papers by this authorXu Jia, Xu Jia orcid.org/0000-0002-1612-1136 Noncoding RNA and Drug Discovery Key Laboratory of Sichuan Province, Chengdu Medical College, Chengdu, Sichuan, ChinaSearch for more papers by this authorYoujun Feng, Corresponding Author Youjun Feng [email protected] orcid.org/0000-0001-8083-0175 Department of Pathogen Biology & Microbiology, and Department of General Intensive Care Unit of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China Clinical Laboratory of Lishui People's Hospital, Lishui, Zhejiang, China Noncoding RNA and Drug Discovery Key Laboratory of Sichuan Province, Chengdu Medical College, Chengdu, Sichuan, China College of Animal Sciences, Zhejiang University, Hangzhou, Zhejiang, China Correspondence Youjun Feng, Department of Pathogen Biology & Microbiology, and Department of General Intensive Care Unit of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310058 Zhejiang, China. Email: [email protected]Search for more papers by this author First published: 13 April 2020 https://doi.org/10.1002/jmv.25869Citations: 1 Funding Information: National Natural Science Foundation of China, Grant/Award Number: 31830001 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Supporting Information Filename Description jmv25869-sup-0001-fig_S1_chest_CT_description.tif28.9 MB Supporting information jmv25869-sup-0002-SupMat.docx25.5 KB Supporting information Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article. REFERENCES 1Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382: 727-733. 10.1056/NEJMoa2001017 CASPubMedWeb of Science®Google Scholar 2Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382: 1708–1720. 10.1056/NEJMoa2002032 CASPubMedWeb of Science®Google Scholar 3Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020; 323: 1239. 10.1001/jama.2020.2648 CASPubMedWeb of Science®Google Scholar 4Xu Y, Wang L, Jia X, Feng Y. 2019-nCoV: a possible progenitor for SARS-CoV with bat origin? PrePrint. 2020. https://doi.org/10.20944/preprints202003.0159.v1 Google Scholar 5Hu D, Zhu C, Ai L, et al. Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats. Emerg Microbes Infect. 2018; 7(1): 154-10. 10.1038/s41426-018-0155-5 PubMedWeb of Science®Google Scholar 6Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223): 507-513. 10.1016/S0140-6736(20)30211-7 CASPubMedWeb of Science®Google Scholar 7Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020; 20: 425-434. 10.1016/S1473-3099(20)30086-4 CASPubMedWeb of Science®Google Scholar 8Zhang H, Wang W, Wu N, et al. Influenza-like illness caused by the 2019 novel coronavirus (2019-nCoV) via the person-to-person transmission. PrePrint. 2020. https://doi.org/10.20944/preprints202003.200160.v202001 Google Scholar Citing Literature Volume92, Issue10Special Issue on New coronavirus (2019‐nCoV or SARS‐CoV‐2) and the outbreak of the respiratory illness (COVID‐19): Part‐VIOctober 2020Pages 1764-1766 ReferencesRelatedInformation

Comment on Yang Et Al., Development of a Monoclonal Antibody‐based Antigen Capture Enzyme‐linked Immunosorbent Assay for Detection of H7N9 Subtype Avian Influenza Virus. J Med Virol. 2021; 93:3939‐3943

Laboratory findings in patients with avian-origin influenza A (H7N9) virus infections.

Cross-reactivity between avian influenza A (H7N9) virus and divergent H7 subtypic- and heterosubtypic influenza A viruses

Detection of Antibodies Against SARS‐CoV‐2 in Patients with COVID‐19

Evaluating Agreement in Different Diagnosis Methods is Necessary

Development of a Colloidal Gold-Based Immunochromatographic Strip Test Using Two Monoclonal Antibodies to Detect H7N9 Avian Influenza Virus.

Establishing a Multicolor Flow Cytometry to Characterize Cellular Immune Response in Chickens Following H7N9 Avian Influenza Virus Infection

Development of Rapid Immunochromatographic Test for Hemagglutinin Antigen of H7 Subtype in Patients Infected with Novel Avian Influenza A (H7N9) Virus

Development of a monoclonal antibody-based antigen capture enzyme-linked immunosorbent assay for detection of H7N9 subtype avian influenza virus

Influenza‐like Illnesses Caused by a Cluster of Imported Italian COVID‐19

Antigen-capture ELISA and immunochromatographic test strip to detect the H9N2 subtype avian influenza virus rapidly based on monoclonal antibodies

Development of an Antigen-Capture Enzyme-Linked Immunosorbent Assay and Immunochromatographic Strip Based on Monoclonal Antibodies for Detection of H6 Avian Influenza Viruses

Human Infections with the Emerging Avian Influenza A H7N9 Virus from Wet Market Poultry: Clinical Analysis and Characterisation of Viral Genome

Avian-origin influenza A(H7N9) infection in influenza A(H7N9)-affected areas of China: a serological study.

Generation of Neutralizing and Non-Neutralizing Monoclonal Antibodies Against H7N9 Influenza Virus.

Generation and Characterization of Monoclonal Antibodies Against the Hemagglutinin of H3N2 Influenza A Viruses.

Global Health Concerns Stirred by Emerging Viral Infections

The Protective Effects of the A/ZJU01/ PR8/2013 Split H7N9 Avian Influenza Vaccine Against Highly Pathogenic H7N9 in BALB/c Mice.

Development of an Antigen-Elisa and a Colloidal Gold–based Immunochromatographic Strip Based on Monoclonal Antibodies for Detection of Avian Influenza A(H5) Viruses

Recombinant influenza A virus hemagglutinin HA2 subunit protects mice against influenza A(H7N9) virus infection

Profiles of Acute Cytokine and Antibody Responses in Patients Infected with Avian Influenza A H7N9.